North America Custom Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service (Antibody Development, Antibody Production and Purification, and Antibody Fragmentation and Labelling); Type (Monoclonal Antibodies, Polyclonal Antibodies, and Other Custom Antibodies); Source (Mice, Rabbits, and Others); Research Area (Oncology, Immunology, Stem Cells, Infectious Diseases, Neurobiology, Cardiovascular Diseases, and Others); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations)
Market Introduction
Customized antibodies can be generated in a mouse, rat, or hamster, to meet any host requirements. Companies are providing a wide range of antibodies according to the researcher's requirements. There are various customized antibodies in the market, including polyclonal and monoclonal antibodies, recombinant monoclonal antibodies, hybridoma antibodies, polyclonal recombinant antibodies, etc. In addition, companies offer complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titre analysis, and final antibody purification.
Thus, the high demand in research is expected to create a significant demand for custom antibody in the coming years, which is further anticipated to drive the custom antibody market.
The approval of custom antibody services has expanded for the development of COVID-19 vaccines. The companies engaging in the custom antibody market, including Thermo Fisher Scientific (US) and Abcam plc (US), witnessed a negative impact on their services in early 2020 due to the temporary shutdown of their laboratories. However, as lockdown limitations were gradually lifted, research laboratories around the world started reopening. As a result, most service providers prioritized actions to promote the critical work of consumers included in COVID-19, such as giving a range of high-quality COVID-19 related research tools, reassigning R&D resources for producing essential products for SARS-Cov-2, expanding the supply chain, and making flexibility to support expanded demand for enduring products applied for SARS-CoV-2/COVID-19 research, and entering into discussions and collaborations across the UK, US, and China concentrated on SARS-CoV-2 diagnostics, drugs, and vaccines development. As per the reports of Abcam plc., the company witnessed 6.7% growth in the first half of 2021 compared to the same period in 2020. Custom Products & Licensing (CP&L) revenue has seen an increase of 15.9%. Additionally, Thermo Fisher Scientific observed 15.2% growth in the third quarter of 2020 compared to the same period in 2020. Considering these it can be declared that the impact of COVID-19 on the custom antibody market has been positive. Therefore, the COVID19 pandemic is expected to positively impact the custom antibody market.
Get more information on this report :
Market Overview and Dynamics
The Custom antibody market in North America is expected to grow from US$ 186.5 million in 2021 to US$ 374.3 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2021 to 2028. Advancements in medical technologies provide support for the faster and highly efficient discoveries for antibodies that can be customized as per the customers’ requirements. Integrating bioinformatics in the discovery of antibodies has triggered improvements in custom antibody research. Therefore, artificial intelligence (AI) is likely to emerge as an essential, value addition tool for the discovery of custom antibodies. Oncology research is an emerging field for the application of custom monoclonal antibodies. Most of the clinical trials are performed using monoclonal antibodies derived from rabbits. For instance, anti-VEGF, a humanized anti-vascular growth endothelial factor (rabbit mAb) is currently under clinical studies for the evaluation of its effects on metastatic colorectal cancer and other solid tumors. Likewise, anti-VEGF is under clinical studies for its use in treating age-related macular degeneration. Monoclonal antibodies of derived from rabbits are proven as a superior alternative to mouse-derived monoclonal antibodies due to the presence of a larger complementarity determining region (CDR) in the antigen-binding site. In addition, monoclonal antibodies have capabilities to produce higher affinity clones. Various other sources are being evaluated for custom antibodies discoveries. Therefore, these discoveries are likely to enhance the growth of the custom antibody market during the forecast period.
Key Market Segments
In terms of service, the antibody development segment accounted for the largest share of the North America custom antibody market in 2020. In terms of type, the monoclonal antibodies segment accounted for the largest share of the North America custom antibody market in 2020. In terms of source, the mice segment accounted for the largest share of the North America custom antibody market in 2020. In terms of research area, the oncology segment held a larger market share of the custom antibody market in 2020. In terms of end user, the pharmaceutical and biotechnology companies segment held a larger market share of the custom antibody market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the custom antibody market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck KGAA, Abcam, Genscript, Rockland Immunochemicals, Inc., Promab, Biolegend, Inc., Agilent Technologies, Inc., and Cell Signaling Technology, Inc.
Reasons to buy report
- To understand the North America custom antibody market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America custom antibody market
- Efficiently plan M&A and partnership deals in North America Custom antibody market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America Custom antibody market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA CUSTOM ANTIBODY MARKET SEGMENTATION
By Service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Rockland Immunochemicals, Inc.
- Promab
- Biolegend, Inc.
- Agilent Technologies, Inc.
- Cell Signaling Technology, Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Custom Antibody Market – By Service
1.3.2 Custom Antibody Market – By Type
1.3.3 Custom Antibody Market – By Source
1.3.4 Custom Antibody Market – By Research Area
1.3.5 Custom Antibody Market – By End User
1.3.6 North America Custom Antibody Market – By Country
2. North America Custom Antibody Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Custom Antibody Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Custom Antibody Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Custom Antibody Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Demand in Research
5.1.2 Market Consolidations Strategies Adopted by Biotechnology Companies
5.1.3 Production and Development Services Offered by Custom Antibody Providers
5.2 Market Restraints
5.2.1 High Cost of Production
5.3 Future Trends
5.3.1 Developments for Custom Antibodies
5.4 Impact Analysis
6. Custom Antibody Market – North America Analysis
6.1 North America Custom Antibody Market Revenue Forecasts and Analysis
7. North America Custom Antibody Market Analysis and Forecasts To 2028 – By Service
7.1 Overview
7.2 Custom Antibody Market Revenue Share, by Service (2020 and 2028)
7.3 Antibody Development
7.3.1 Overview
7.3.2 Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Antibody Production and Purification
7.4.1 Overview
7.4.2 Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Antibody Fragmentation and Labelling
7.5.1 Overview
7.5.2 Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8. North America Custom Antibody Market Analysis and Forecasts To 2028 – By Type
8.1 Overview
8.2 Custom Antibody Market Revenue Share, by Type (2020 and 2028)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Polyclonal Antibodies
8.4.1 Overview
8.4.2 Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Other Custom Antibodies
8.5.1 Overview
8.5.2 Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
9. North America Custom Antibody Market Analysis and Forecasts To 2028 – By Source
9.1 Overview
9.2 Custom Antibody Market Revenue Share, By Source (2020 and 2028)
9.3 Mice
9.3.1 Overview
9.3.2 Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Rabbit
9.4.1 Overview
9.4.2 Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Custom Antibody Market Analysis and Forecasts to 2028– By Research Area
10.1 Overview
10.2 Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Immunology
10.4.1 Overview
10.4.2 Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Stem Cells
10.5.1 Overview
10.5.2 Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Disease
10.6.1 Overview
10.6.2 Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Neurobiology
10.7.1 Overview
10.7.2 Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Cardiovascular Disease
10.8.1 Overview
10.8.2 Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Custom Antibody Market Analysis and Forecasts to 2028– By End User
11.1 Overview
11.2 Custom Antibody Market Revenue Share, by End User (2020 and 2028)
11.3 Pharmaceutical and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.4 Academic and Research Institutes
11.4.1 Overview
11.4.2 Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.5 Contract Research Organizations
11.5.1 Overview
11.5.2 Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
12. Custom Antibody Market Revenue and Forecasts to 2028 – Geographical Analysis
12.1 North America: Custom Antibody Market Revenue and Forecast to 2028
12.1.1 Overview
12.1.2 North America: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.1.2.1 US: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 US: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 US: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.1.3 US: Custom antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.1.4 US: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.1.5 US: Custom antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.1.6 US: Custom antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.2 Canada: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Canada: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 Canada: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.2.3 Canada: Custom antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.2.4 Canada: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.2.5 Canada: Custom antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.2.6 Canada: Custom antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.3 Mexico: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 Mexico: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 Mexico: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.3.3 Mexico: Custom antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.3.4 Mexico: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.3.5 Mexico: Custom antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.3.6 Mexico: Custom antibody Market, by End User, 2019–2028 (USD Million)
13. Impact Of COVID-19 Pandemic on North America Custom Antibody Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
14. Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. COMPANY PROFILES
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 BIO-RAD LABORATORIES INC.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 MERCK KGaA
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 ABCAM
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 GenScript
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Rockland Immunochemicals, Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 ProMab
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 BioLegend, Inc.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Agilent Technologies, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Cell Signaling Technology, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 2. US: Custom antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 4. US: Custom antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 5. US: Custom antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Custom antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Custom antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Custom antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Custom antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Custom antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Custom antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 16. Recent Inorganic Growth Strategies in the Custom Antibody Market
Table 17. Recent Organic Growth Strategies in the Custom Antibody Market
Table 18. Glossary of Terms, Custom Antibody Market
LIST OF FIGURES
Figure 1. Custom Antibody Market Segmentation
Figure 2. North America Custom Antibody Market Overview
Figure 3. Antibody Development Segment Held Largest Share of Service in Custom Antibody Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Custom Antibody Market - North America PEST Analysis
Figure 6. Custom Antibody Market Impact Analysis of Driver and Restraints
Figure 7. North America Custom Antibody Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Custom Antibody Market Revenue Share, by Service (2020 and 2028)
Figure 9. Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Custom Antibody Market Revenue Share, by Type (2020 and 2028)
Figure 13. Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Custom Antibody Market Revenue Share, by Source (2020 and 2028)
Figure 17. Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
Figure 21. Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Custom Antibody Market Revenue Share, by End User (2020 and 2028)
Figure 29. Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Custom Antibody Market , by Key Country – Revenue (2020) (USD Million)
Figure 33. North America: Custom Antibody Market , by Country, 2020 & 2028 (%)
Figure 34. US: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North American Country Markets
Figure 38. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Rockland Immunochemicals, Inc.
- Promab
- Biolegend, Inc.
- Agilent Technologies, Inc.
- Cell Signaling Technology, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America custom antibody market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America custom antibody market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the custom antibody market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution